Provided by Tiger Trade Technology Pte. Ltd.

Rapport Therapeutics, Inc.

40.45
-1.5000-3.58%
Post-market: 40.450.00000.00%19:30 EDT
Volume:998.06K
Turnover:40.50M
Market Cap:1.94B
PE:-13.25
High:43.00
Open:41.89
Low:40.29
Close:41.95
52wk High:52.93
52wk Low:23.75
Shares:47.98M
Float Shares:30.39M
Volume Ratio:3.51
T/O Rate:3.28%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.0525
EPS(LYR):-2.8633
ROE:-39.96%
ROA:-25.78%
PB:4.59
PE(LYR):-14.13

Loading ...

Rapport Therapeutics price target raised to $75 from $65 at BTIG

TIPRANKS
·
Sep 16

Rapport Therapeutics, Inc. : Btig Raises Target Price to $75 from $65

THOMSON REUTERS
·
Sep 16

U.S. Research Roundup-Domino's, McDonald's, Starbucks

Reuters
·
Sep 16

Rapport Therapeutics CEO Abraham Ceesay Sells $373,980 of Common Shares

Reuters
·
Sep 10

Analysts Conflicted on These NA Names: Fiserv (FISV) and Rapport Therapeutics, Inc. (RAPP)

TIPRANKS
·
Sep 02

Rapport Therapeutics to Join Cantor Global Healthcare Conference Fireside Chat

Reuters
·
Sep 02

Rapport Therapeutics to Participate in Upcoming Investor Conferences

GlobeNewswire
·
Sep 02

Rapport Therapeutics Chief Development Officer Krishnaswamy Yeleswaram Disposes of Common Shares Worth $2.51 Million

Reuters
·
Aug 27

Rapport Therapeutics to Host Virtual KOL Event on Bipolar Mania and RAP-219 Program

Reuters
·
Aug 24

Rapport Therapeutics Chief Development Officer Krishnaswamy Yeleswaram Disposes of 404 Common Shares Worth $20,159.6

Reuters
·
Aug 21

Analysts Have Conflicting Sentiments on These NA Companies: ServiceTitan, Inc. Class A (TTAN), Rapport Therapeutics, Inc. (RAPP) and Amentum Holdings, Inc. (AMTM)

TIPRANKS
·
Aug 20

Analysts Offer Insights on NA Companies: Rapport Therapeutics, Inc. (RAPP) and SpaceX (SPCX)

TIPRANKS
·
Aug 20

Does Widening Losses And Higher EPS Drag Change The Bull Case For Rapport Therapeutics (RAPP)?

Simply Wall St.
·
Aug 20

Rapport Therapeutics Price Target Maintained with a $65.00/Share by BTIG

Dow Jones
·
Aug 19

Rapport Therapeutics price target raised to $75 from $68 at Raymond James

TIPRANKS
·
Aug 17

Rapport Therapeutics, Inc. (RAPP) Receives a Buy from Stifel Nicolaus

TIPRANKS
·
Aug 13

Rapport Therapeutics CEO Abraham Ceesay Sells 51,499 Shares Worth $2.41 Million

Reuters
·
Aug 13

Rapport Therapeutics Price Target Raised to $66.00/Share from $40.00 by HC Wainwright & Co.

Dow Jones
·
Aug 13

Douglas Tsao Boosts Rapport Therapeutics Price Target to $66 on Strong RAP-219 Differentiation and Robust Phase 2 Data

TIPRANKS
·
Aug 13

Analysts Offer Insights on NA Companies: Rapport Therapeutics, Inc. (RAPP) and Honeywell Aerospace (HONA)

TIPRANKS
·
Aug 06